Related Experiment Video
Updated: Jul 6, 2026

06:08
Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
Published on: September 22, 2023
Developing a rabbit model of rhinogenic chronic rhinosinusitis
Kai-Li Liang1, Rong-San Jiang, John Wang
1Department of Otolaryngology, Taichung Veterans General Hospital, Chung Shan Medical University Hospital, Taichung, Taiwan. kelly1107@vghtc.gov.tw
The Laryngoscope
|April 5, 2008
Summary
This study successfully created a rabbit model for rhinogenic chronic rhinosinusitis (CRS). The developed model is easily reproducible and demonstrates reversibility with antibiotic treatment.
Area of Science:
- Otorhinolaryngology
- Animal Models
- Inflammatory Diseases
Background:
- Chronic rhinosinusitis (CRS) poses a significant clinical challenge.
- Developing reliable animal models is crucial for understanding CRS pathogenesis and testing therapies.
Purpose of the Study:
- To establish a novel rabbit model for rhinogenic chronic rhinosinusitis (CRS).
- To evaluate the efficacy of antibiotic treatment in the developed CRS model.
Main Methods:
- New Zealand white rabbits were utilized, with two experimental groups.
- Group A involved Merocel sponge insertion, while Group B included phorbol 12-myristate 13-acetate (PMA) injection followed by Merocel insertion.
- Diagnosis of CRS was confirmed via CT scans, nasoendoscopy, and cultures; treatment efficacy was assessed with ceftriaxone.
Main Results:
- CRS developed in multiple nasal cavities across different experimental conditions at week 12.
- Antibiotic treatment with ceftriaxone significantly cleared sinus opacification in seven of nine treated sides.
- Untreated CRS sites showed persistent disease, with significant differences in CRS incidence and culture rates between treated and untreated groups.
Conclusions:
- A reproducible rabbit model for rhinogenic CRS has been successfully developed.
- This model is characterized by its ease of implementation and responsiveness to therapeutic intervention.
- The model shows promise for future research into CRS pathophysiology and treatment strategies.
